Palmetto GBA issues final local coverage determination for ProMark

In The Headlines: When DOGE fires you from your dream job

In this episode of In the Headlines, Jacquelyn Cobb, associate editor of the The Cancer Letter, and Claire Marie Porter, reporter, discuss Claire’s interview with an NCI employee who was fired just days after returning from parental leave.

March 05, 2025

Vol.51 No.08

Capitol Hill

Pushing for tax cuts, Trump threatens the federal workforce, Medicaid, and cancer research

The House Republicans have narrowly pushed through a FY25 budget resolution, setting off a tangle of life-and-death sequelae for access to health insurance through Medicaid and Obamacare, and through a second-order effect, biomedical research.

February 28, 2025

Vol.51 No.08

By Paul Goldberg and Jacquelyn Cobb

White House

Fired NCI employee says Trump’s purge was baseless yet punitive
“I feel like I’ve been erased”

On the evening of Feb. 15, when the dreaded letter of termination arrived, an NCI employee was just a few weeks away from job security—the end of the probationary period.

February 28, 2025

Vol.51 No.08

By Claire Marie Porter

Guest Editorial

Telling our stories: Bidirectional benefits of sharing our history

Knowledge is power, and this information, true for many cancers, is valuable for everyone to know—either to have an awareness of their own bodies and the factors that they can control, or to create spaces for empathy with persons they might encounter with cancer.

February 28, 2025

Vol.51 No.08

By W. Kimryn Rathmell

Black History Month Conversation with The Cancer Letter

Shearwood McClelland III: “When you stand for something, you’re always going to be attacked.”

Shearwood McClelland III’s grandfather was a ditchdigger who dreamed that his six Black daughters would become doctors. McClelland’s mother did not disappoint—she became the first Black woman board-certified in maternal fetal medicine in the history of the United States. Now, McClelland is the chief medical officer of Cancer Health Equity at the University of Oklahoma...

Biomarker-driven innovation: What the FDA’s evolving strategy means for oncology

As oncology enters a new era of precision medicine, the Food and Drug Administration’s evolving biomarker strategy aims to ensure that life-saving therapies are tailored to individual patient needs, fostering safer and more effective treatments. Historically, therapies were approved with broad indications based on overall efficacy, even when outcomes for biomarker-positive and -negative patients were...

February 28, 2025

Vol.51 No.08

By Harpreet Singh

Palmetto GBA issues final local coverage determination for ProMark

YOU MAY BE INTERESTED IN

In The Headlines: When DOGE fires you from your dream job

Pushing for tax cuts, Trump threatens the federal workforce, Medicaid, and cancer research

Fired NCI employee says Trump’s purge was baseless yet punitive
“I feel like I’ve been erased”

Telling our stories: Bidirectional benefits of sharing our history

Shearwood McClelland III: “When you stand for something, you’re always going to be attacked.”

Biomarker-driven innovation: What the FDA’s evolving strategy means for oncology

Renew today!

Subscriber content

Palmetto GBA issues final local coverage determination for ProMark

YOU MAY BE INTERESTED IN

In The Headlines: When DOGE fires you from your dream job

Pushing for tax cuts, Trump threatens the federal workforce, Medicaid, and cancer research

Fired NCI employee says Trump’s purge was baseless yet punitive“I feel like I’ve been erased”

Telling our stories: Bidirectional benefits of sharing our history

Shearwood McClelland III: “When you stand for something, you’re always going to be attacked.”

Biomarker-driven innovation: What the FDA’s evolving strategy means for oncology

Fired NCI employee says Trump’s purge was baseless yet punitive
“I feel like I’ve been erased”